Literature DB >> 9558387

gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6.

X J Wang1, T Taga, K Yoshida, M Saito, T Kishimoto, H Kikutani.   

Abstract

gp130 is a common signal-transducing receptor component for the interleukin-6 (IL-6) family of cytokines. To investigate the expression of gp130 in T-cell subsets and its regulation, anti-murine gp130 monoclonal antibody (MoAb) was used for flow cytometric analysis. In normal mice, gp130 was differentially expressed in thymocyte and splenic T-cell subpopulations defined by CD4/CD8 expression. In aged MRL/lpr mice, although gp130 expression was detectable in splenic CD4(+) or CD8(+) T cells, gp130 expression was significantly downregulated. Because serum levels of IL-6 and soluble IL-6 receptor (sIL-6R) are elevated in these mice, we examined the possibility that the downregulation of gp130 expression on splenic T cells might be produced in response to continuous activation of gp130 by high levels of serum IL-6. In transgenic mice overexpressing IL-6, gp130 expression in the splenic T cells was significantly decreased. After stimulation with IL-6 in vitro, the level of gp130 on CD4(+) or CD8(+) splenic T cells from normal mice was significantly decreased. These results suggest that the expression of gp130 in splenic T cells could be downregulated by the IL-6 stimulation under physiological or pathological circumstances.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558387

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells.

Authors:  Longbiao Yao; Takafumi Yokota; Lijun Xia; Paul W Kincade; Rodger P McEver
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

3.  IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.

Authors:  Lei Wang; Andrea K Miyahira; Diana L Simons; Xuyang Lu; Andrew Y Chang; Carrie Wang; Maria A Suni; Vernon C Maino; Frederick M Dirbas; John Yim; James Waisman; Peter P Lee
Journal:  Cancer Res       Date:  2016-11-22       Impact factor: 12.701

Review 4.  gp130 at the nexus of inflammation, autoimmunity, and cancer.

Authors:  J S Silver; C A Hunter
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

5.  IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells.

Authors:  Zhiwu Jiang; Rui Liao; Jiang Lv; Shanglin Li; Diwei Zheng; Le Qin; Di Wu; Suimin Chen; Youguo Long; Qiting Wu; Suna Wang; Simiao Lin; Xiaohan Huang; Zhaoyang Tang; Pengcheng Shi; Hongsheng Zhou; Qifa Liu; Ruocong Zhao; Yangqiu Li; Yang Jie; Wei Wei; Peilong Lai; Xin Du; Shuzhong Cui; Robert Weinkove; Pentao Liu; Duanqing Pei; Yao Yao; Peng Li
Journal:  Leukemia       Date:  2020-11-09       Impact factor: 11.528

6.  TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity.

Authors:  Stacey N Harbour; Daniel F DiToro; Steven J Witte; Carlene L Zindl; Min Gao; Trenton R Schoeb; Gareth W Jones; Simon A Jones; Robin D Hatton; Casey T Weaver
Journal:  Sci Immunol       Date:  2020-07-17

7.  Interleukin-6 contributes to age-related alteration of cytokine production by macrophages.

Authors:  Christian R Gomez; John Karavitis; Jessica L Palmer; Douglas E Faunce; Luis Ramirez; Vanessa Nomellini; Elizabeth J Kovacs
Journal:  Mediators Inflamm       Date:  2010-07-07       Impact factor: 4.711

8.  Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.

Authors:  T Robak; A Wierzbowska; M Błasińska-Morawiec; A Korycka; J Z Błoński
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

Review 9.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01

10.  Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation.

Authors:  Daniel Meley; Audrey Héraud; Valerie Gouilleux-Gruart; Fabrice Ivanes; Florence Velge-Roussel
Journal:  Front Immunol       Date:  2017-08-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.